Neff, Lisa M.
Eli Lilly (United States)
6 papers on CoChatORCID 0000-0002-3006-6057
Most cited papers
- Verified
Vitamin D supplementation and prevention of type 2 diabetes
Pittas, A. G., Dawson-Hughes, B., Sheehan, P., Ware, J. H., Knowler, W. C., Aroda, V. R., Brodsky, I., Ceglia, L., Chadha, C., Chatterjee, R., et al. (2019) · New England Journal of Medicine
Vitamin D Research StudiesDiabetes Treatment and Management
Cited by 673
- Verified
Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 Diabetes (D2d) study
Dawson-Hughes, B., Staten, M. A., Knowler, W. C., Nelson, J., Vickery, E. M., LeBlanc, E. S., Neff, L. M., Park, J., & Pittas, A. G. (2020) · Diabetes Care
Vitamin D Research StudiesNutritional Studies and Diet
Cited by 192
- Verified
Nutritional considerations with antiobesity medications
Almandoz, J. P., Wadden, T. A., Tewksbury, C., Apovian, C. M., Fitch, A., Ard, J. D., Li, Z., Richards, J., Butsch, W. S., Jouravskaya, I., et al. (2024) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 134
- Verified
Algal Docosahexaenoic Acid Affects Plasma Lipoprotein Particle Size Distribution in Overweight and Obese Adults
Neff, L. M., Culiner, J., Cunningham-Rundles, S., Seidman, C., Meehan, D., Maturi, J., Wittkowski, K. M., Levine, B., & Breslow, J. L. (2011) · The Journal of Nutrition
Fatty Acid Research and HealthLipoproteins and Cardiovascular Health
Cited by 121
- Verified
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
Hankosky, E. R., Wang, H., Neff, L. M., Kan, H., Wang, F., Ahmad, N. N., Griffin, R., Stefanski, A., & Garvey, W. T. (2024) · Diabetes, Obesity and Metabolism
Pharmacology and Obesity TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 97
- Verified
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT ‐1 trial
Hankosky, E. R., Wang, H., Neff, L. M., Kan, H., Wang, F., Ahmad, N. N., Stefanski, A., & Garvey, W. T. (2023) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free